Applied Molecular Transport Performance
| AMTIDelisted Stock | USD 0.33 0.00 0.00% |
The firm shows a Beta (market volatility) of 1.63, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Applied Molecular will likely underperform. Applied Molecular right now shows a risk of 0.0%. Please confirm Applied Molecular treynor ratio and the relationship between the semi variance and relative strength index , to decide if Applied Molecular will be following its price patterns.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Applied Molecular Transport has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong basic indicators, Applied Molecular is not utilizing all of its potentials. The recent stock price confusion, may contribute to short-horizon losses for the traders. ...more
| Begin Period Cash Flow | 160.8 M | |
| Total Cashflows From Investing Activities | -4.2 M |
Applied |
Applied Molecular Relative Risk vs. Return Landscape
If you would invest 33.00 in Applied Molecular Transport on August 25, 2024 and sell it today you would earn a total of 0.00 from holding Applied Molecular Transport or generate 0.0% return on investment over 90 days. Applied Molecular Transport is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than Applied, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Applied Molecular Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Applied Molecular's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Applied Molecular Transport, and traders can use it to determine the average amount a Applied Molecular's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| AMTI |
Based on monthly moving average Applied Molecular is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Applied Molecular by adding Applied Molecular to a well-diversified portfolio.
Applied Molecular Fundamentals Growth
Applied Stock prices reflect investors' perceptions of the future prospects and financial health of Applied Molecular, and Applied Molecular fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Applied Stock performance.
| Return On Equity | -1.58 | |||
| Return On Asset | -0.51 | |||
| Current Valuation | (5.88 M) | |||
| Shares Outstanding | 41.85 M | |||
| Price To Book | 0.70 X | |||
| EBITDA | (127.22 M) | |||
| Cash And Equivalents | 95.83 M | |||
| Cash Per Share | 2.46 X | |||
| Total Debt | 36.12 M | |||
| Debt To Equity | 0.38 % | |||
| Book Value Per Share | 0.40 X | |||
| Cash Flow From Operations | (93.9 M) | |||
| Earnings Per Share | (1.89) X | |||
| Total Asset | 107.45 M | |||
| Retained Earnings | (365.97 M) | |||
About Applied Molecular Performance
By evaluating Applied Molecular's fundamental ratios, stakeholders can gain valuable insights into Applied Molecular's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Applied Molecular has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Applied Molecular has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Applied Molecular Transport Inc., a clinical-stage biopharmaceutical company, engages in the design and development of a pipeline of oral and respiratory biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. Applied Molecular Transport Inc. was founded in 2010 and is headquartered in South San Francisco, California. Applied Molecular operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 125 people.Things to note about Applied Molecular performance evaluation
Checking the ongoing alerts about Applied Molecular for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Applied Molecular help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Applied Molecular is not yet fully synchronised with the market data | |
| Applied Molecular has some characteristics of a very speculative penny stock | |
| Applied Molecular has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (126.33 M) with loss before overhead, payroll, taxes, and interest of (42.08 M). | |
| Applied Molecular Transport currently holds about 95.83 M in cash with (93.9 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.46, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 21.0% of the company shares are held by company insiders |
- Analyzing Applied Molecular's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Applied Molecular's stock is overvalued or undervalued compared to its peers.
- Examining Applied Molecular's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Applied Molecular's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Applied Molecular's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Applied Molecular's stock. These opinions can provide insight into Applied Molecular's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Other Consideration for investing in Applied Stock
If you are still planning to invest in Applied Molecular check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Applied Molecular's history and understand the potential risks before investing.
| CEOs Directory Screen CEOs from public companies around the world | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |